MapLight Therapeutics, Inc. - Common Stock (MPLT)
Stock listed on Nasdaq Stock Market (NASDAQ) · Pharmaceutical Preparations · prices in USD
Price
7.97 USD−0.28 (−3.39%)Close on (end-of-day, stored)
Key statistics · as of Oct 23, 2026
- 52-week range
- 7.46 – 40.43
- Market cap
- 338.2M USD
- P/E
- —
- P/B
- 1.0
- EV/EBITDA
- —
- Dividend yield
- —
- 1-year return
- —
- 3-month return
- −19.5%
- Volatility (1y)
- 155.3%
- Max drawdown (1y)
- −80.7%
- Beta (1y)
- 0.87
- RSI (14)
- 30
- Revenue growth
- —
- ROE
- −66.0%
- ROIC
- —
- Debt / equity
- —
Ratios are calculated by AlphaScope from stored prices and reported financial statements; see the methodology. Blank values mean the data is not available.
Financial statements · annual · USD
| Fiscal year ending | Dec 31, 2025 | Dec 31, 2024 |
|---|---|---|
| Operating income | -169.1M | -82.9M |
| Net income | -161.2M | -77.6M |
| EPS (diluted) | −18.56 | −105.38 |
| Total assets | 479.5M | 136.9M |
| Total liabilities | 21.1M | 21.7M |
| Shareholders’ equity | 458.4M | -193.6M |
| Operating cash flow | -138.1M | -78.8M |
| Free cash flow | -138.6M | -79.6M |
Source: SEC EDGAR companyfacts. Full income statement, balance sheet and cash flow, quarterly and trailing-twelve-month views are in the app.
Peers · Pharmaceutical Preparations
| Company | Market cap | 1-year return |
|---|---|---|
| Eli Lilly and Company (LLY) | 1.2T | +57.8% |
| Johnson & Johnson (JNJ) | 635.2B | +39.8% |
| AbbVie Inc. (ABBV) | 504.7B | +27.8% |
| Merck & Co., Inc. (MRK) | 358.4B | +70.7% |
| Novartis AG Common Stock (NVS) | 288.4B | +18.5% |
| Abbott Laboratories (ABT) | 180.6B | −17.5% |
| Pfizer Inc. (PFE) | 171.1B | +29.9% |
| Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) | 135.6B | +25.5% |
MPLT news
No stored headlines.